Cargando…

Effects of beclomethasone/formoterol fixed combination on lung hyperinflation and dyspnea in COPD patients

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a common disease characterized by airflow obstruction and lung hyperinflation leading to dyspnea and exercise capacity limitation. OBJECTIVES: The present study was designed to evaluate whether an extra-fine combination of beclomethasone an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tzani, Panagiota, Crisafulli, Ernesto, Nicolini, Gabriele, Aiello, Marina, Chetta, Alfredo, Clini, Enrico Maria, Olivieri, Dario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206766/ https://www.ncbi.nlm.nih.gov/pubmed/22069361 http://dx.doi.org/10.2147/COPD.S23746

Ejemplares similares

Dynamic hyperinflation is associated with a poor cardiovascular response to exercise in COPD patients
por: Tzani, Panagiota, et al.
Publicado: (2011)

Beclomethasone/Formoterol in Extra-Fine Formulation Improves Small Airway Dysfunction in COPD Patients
por: Pisi, Roberta, et al.
Publicado: (2021)

Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations
por: Nicolini, Gabriele, et al.
Publicado: (2008)

Extrafine Beclomethasone/formoterol compared to Fluticasone/salmeterol Combination Therapy in COPD
por: Singh, Dave, et al.
Publicado: (2014)

Baseline Exercise Tolerance and Perceived Dyspnea to Identify the Ideal Candidate to Pulmonary Rehabilitation: A Risk Chart in COPD Patients
por: Costi, Stefania, et al.
Publicado: (2019)

Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide
por: Singh, Dave, et al.
Publicado: (2017)

Measures of dyspnea in pulmonary rehabilitation
por: Crisafulli, Ernesto, et al.
Publicado: (2010)

Management of severe COPD exacerbations: focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide
por: Mantero, Marco, et al.
Publicado: (2018)

Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD
por: Montuschi, Paolo, et al.
Publicado: (2018)

Small airway dysfunction is associated to excessive bronchoconstriction in asthmatic patients
por: Alfieri, Veronica, et al.
Publicado: (2014)

The value of high-resolution computed tomography (HRCT) to determine exercise ventilatory inefficiency and dynamic hyperinflation in adult patients with cystic fibrosis
por: Crisafulli, Ernesto, et al.
Publicado: (2019)

New Pharmacologic Perspectives in Pneumology: Beclomethasone-Formoterol Extrafine
por: Paggiaro, Pierluigi
Publicado: (2009)

ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD
por: Watz, Henrik, et al.
Publicado: (2017)

Flow and volume response to bronchodilator in patients with COPD
por: Matteo, Vigna, et al.
Publicado: (2018)

Maximal exercise in obese patients with COPD: the role of fat free mass
por: Aiello, Marina, et al.
Publicado: (2014)

Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease
por: Pisi, Roberta, et al.
Publicado: (2015)

Development of Room Temperature Stable Formulation of Formoterol Fumarate/Beclomethasone HFA pMDI
por: Purohit, D., et al.
Publicado: (2009)

Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways
por: Calzetta, Luigino, et al.
Publicado: (2018)

Inhaled beclomethasone/formoterol in idiopathic pulmonary fibrosis: a randomised controlled exploratory study
por: Wright, Caroline E., et al.
Publicado: (2017)

Rapid effects of extrafine beclomethasone dipropionate/formoterol fixed combination inhaler on airway inflammation and bronchoconstriction in asthma: a randomised controlled trial
por: O'Connor, Brian J, et al.
Publicado: (2011)

The efficacy of extrafine beclomethasone dipropionate–formoterol fumarate in COPD patients who are not “frequent exacerbators”: a post hoc analysis of the FORWARD study
por: Singh, Dave, et al.
Publicado: (2017)

Adiposity increases weight-bearing exercise-induced dyspnea despite favoring resting lung hyperinflation in COPD
por: S, Zewari, et al.
Publicado: (2022)

Role of Inhaled Steroids in Vascular Airway Remodelling in Asthma and COPD
por: Chetta, Alfredo, et al.
Publicado: (2012)

Small Airways, Big Problem: Extrafine beclomethasone/formoterol in asthma and chronic obstructive pulmonary disease
por: Hasan, Ashfaq, et al.
Publicado: (2021)

Respiratory muscles training in COPD patients
por: Crisafulli, Ernesto, et al.
Publicado: (2007)

Airflow limitation or static hyperinflation: which is more closely related to dyspnea with activities of daily living in patients with COPD?
por: Nishimura, Koichi, et al.
Publicado: (2011)

Hyperinflation and its management in COPD
por: Puente-Maestu, Luis, et al.
Publicado: (2006)

Cardiovascular effects of exercise induced dynamic hyperinflation in COPD patients—Dynamically hyperinflated and non-hyperinflated subgroups
por: Lukacsovits, Jozsef, et al.
Publicado: (2023)

Metabolic and cardiorespiratory effects of decreasing lung hyperinflation with budesonide/formoterol in COPD: a randomized, double-crossover, placebo-controlled, multicenter trial
por: Divo, Miguel J., et al.
Publicado: (2020)

Longitudinal changes in lung hyperinflation in COPD
por: Park, Jimyung, et al.
Publicado: (2017)

Aclidinium bromide/formoterol fixed-dose combination therapy for COPD: the evidence to date
por: Moitra, Subhabrata, et al.
Publicado: (2015)

Energy Expenditure at Rest and during Walking in Patients with Chronic Respiratory Failure: A Prospective Two-Phase Case-Control Study
por: Crisafulli, Ernesto, et al.
Publicado: (2011)

Lung Deposition of Inhaled Extrafine Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium Bromide in Healthy Volunteers and Asthma: The STORM Study
por: Usmani, Omar S., et al.
Publicado: (2022)

Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial
por: Beeh, Kai M, et al.
Publicado: (2014)

The role of the bronchial microvasculature in the airway remodelling in asthma and COPD
por: Zanini, Andrea, et al.
Publicado: (2010)

Comparison of Dry-Powder Inhaler and Pressurized Metered-Dose Inhaler Formulations of Extrafine Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium in Patients with COPD: The TRI-D Randomized Controlled Trial
por: Beeh, Kai-Michael, et al.
Publicado: (2021)

Resting hyperinflation and emphysema on the clinical course of COPD
por: Kim, Yeon Wook, et al.
Publicado: (2019)

No room to breathe: the importance of lung hyperinflation in COPD
por: Thomas, Mike, et al.
Publicado: (2013)

Cough, a vital reflex. Mechanisms, determinants and measurements
por: Francesco, Andrani, et al.
Publicado: (2018)

Aclidinium bromide in fixed-dose combination with formoterol fumarate in the management of COPD: an update on the evidence base
por: D’Urzo, Anthony D., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3g93g7kt516trhq6l9tf36lvrs